SARS-CoV-2

Zixi Zhang1,2,3,4, Yichao Xiao1,2,3,4, Qiuzhen Lin1,2,3,4

  • 1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.

概括

这项研究报告了在SARS-CoV-2感染后肺和胆囊动脉伪动脉瘤的第一个病例. 了解这些罕见的血管并发症的发病因子对于患者的治疗结果至关重要.